Hypertension — GCC Nursing Guide

ESC/ESH 2023 & ACC/AHA

Hypertension Clinical Reference for GCC Nurses

Evidence-based guidance covering BP classification, emergencies, pharmacology, measurement technique, lifestyle management, and GCC-specific epidemiology. Aligned with ESC/ESH 2023 and ACC/AHA 2017 guidelines.

Hypertension Classification

ESC/ESH vs ACC/AHA Staging Comparison

Category	ESC/ESH 2023 (mmHg)	ACC/AHA 2017 (mmHg)
Normal	SBP <130 AND DBP <85	SBP <120 AND DBP <80
High Normal / Elevated	SBP 130–139 OR DBP 85–89	SBP 120–129 AND DBP <80
Grade 1 / Stage 1	SBP 140–159 OR DBP 90–99	SBP 130–139 OR DBP 80–89
Grade 2 / Stage 2	SBP 160–179 OR DBP 100–109	SBP ≥140 OR DBP ≥90
Grade 3 / Crisis	SBP ≥180 OR DBP ≥110	SBP ≥180 OR DBP ≥120 (Crisis)
Isolated Systolic	SBP ≥140 AND DBP <90	SBP ≥130 AND DBP <80

Note: ACC/AHA threshold lower (130/80), leading to higher prevalence classification. ESC/ESH maintains 140/90 as treatment threshold for most patients.

White Coat vs Masked Hypertension

White Coat Hypertension

Elevated clinic BP (≥140/90) but normal out-of-clinic BP
Prevalence: 15–30% of clinic hypertensives
Still carries some cardiovascular risk — not truly benign
Diagnose with ABPM or home BP monitoring (HBPM)
Management: lifestyle modification + monitoring; drug therapy individualised

Masked Hypertension

Normal clinic BP (<140/90) but elevated out-of-clinic readings
Higher cardiovascular risk than white coat — often undertreated
Suspect in: young males, smokers, high physical activity, anxiety, alcohol use
Requires ABPM for diagnosis; consider HBPM as screening

ABPM — Indications & Interpretation

Indications for ABPM

Suspected white coat or masked hypertension
Large variability between clinic readings
Hypotensive symptoms on treatment
Nocturnal hypertension assessment
Resistant hypertension evaluation
Ramadan — adjusting antihypertensive timing

ABPM Thresholds

24-hour mean: ≥130/80 mmHg = hypertension
Daytime mean: ≥135/85 mmHg
Night-time mean: ≥120/70 mmHg
Dipping pattern: Normal = 10–20% nocturnal dip; Non-dipper = <10% — higher risk

Home BP Monitoring (HBPM) — Correct Technique

Protocol Steps

Rest quietly for 5 minutes before measuring
Empty bladder prior to measurement
No caffeine or exercise for 30 minutes before
Sit with back supported, feet flat on floor
Use validated upper arm device (wrist devices less reliable)
Take 2 readings, 1 minute apart — record both
Measure morning (before medication) and evening
Continue for 7 days (minimum 5 days usable data)
Discard Day 1 readings; average Days 2–7

HBPM Thresholds

Normal: mean <130/80 mmHg
Hypertension: mean ≥135/85 mmHg

Device Validation

Check ESH validated list or Hypertension Canada
Upper arm preferred over wrist
Cuff size must match arm circumference
Calibrate device annually

Key Nursing PointArm must be at heart level during measurement. Each 4 cm elevation = ~3 mmHg error.

Isolated Systolic Hypertension (ISH) in Elderly

SBP ≥160 mmHg with DBP <90 mmHg
Most common form in adults >60 years
Caused by aortic stiffening and reduced vascular compliance
Wide pulse pressure (PP = SBP − DBP, normal <60)
Treatment: thiazide diuretics (indapamide), dihydropyridine CCBs, ACEi/ARB
Target SBP: 130–139 mmHg if tolerated (avoid <120)
Caution: diastolic hypotension (<60–70) increases coronary risk
Orthostatic hypotension more common — check lying/standing BP

Secondary Hypertension — When to Investigate

Suspect Secondary Cause If:

Age <40 with significant hypertension
Resistant hypertension (≥3 drugs at full dose)
Sudden worsening of previously controlled HTN
Hypokalaemia (unprovoked) or metabolic alkalosis

Key Secondary Causes

Cause	Clues	Screen
Renal artery stenosis	Flash pulmonary oedema, bruits, worsened by ACEi	Renal Doppler, MRA
Primary hyperaldosteronism	Hypokalaemia, incidentaloma — most common secondary cause	ARR (aldosterone:renin ratio)
Phaeochromocytoma	Headache, sweating, palpitations — paroxysmal	Plasma/urine metanephrines
Cushing's syndrome	Central obesity, striae, buffalo hump, hyperglycaemia	Overnight dexamethasone suppression
Thyroid/parathyroid	TFTs abnormal, hypercalcaemia	TFTs, PTH, Ca2+
OSA	Snoring, daytime somnolence, non-dipping on ABPM	Sleep study

Hypertensive Emergencies

Hypertensive Emergency = Severely elevated BP + End-Organ DamageRequires immediate IV treatment in ICU/HDU setting. Target: reduce MAP by no more than 25% in the first hour. Do NOT over-correct — cerebral autoregulation resets at chronic hypertension levels.

Urgency vs Emergency

Feature	Hypertensive Urgency	Hypertensive Emergency
BP level	SBP ≥180 or DBP ≥120	SBP ≥180 or DBP ≥120
End-organ damage	Absent	Present (see below)
Symptoms	Headache, anxiety, epistaxis	Neurological, chest pain, dyspnoea
Setting	Outpatient/ED	ICU/HDU mandatory
Treatment	Oral agents, 24–48h reduction	IV agents, controlled reduction
Examples	Non-adherence, pain, white coat	Encephalopathy, ACS, dissection, eclampsia

End-Organ Damage Recognition

Neurological

Encephalopathy: headache, vomiting, confusion, papilloedema, seizure
Ischaemic or haemorrhagic stroke
Subarachnoid haemorrhage

Cardiovascular

Acute coronary syndrome (ACS)
Acute heart failure / pulmonary oedema
Aortic dissection

Other

Acute kidney injury (AKI)
Hypertensive retinopathy (grade 3–4)
Eclampsia / HELLP syndrome
Microangiopathic haemolytic anaemia

Hypertensive Encephalopathy

Clinical Features

Severe headache, nausea/vomiting
Confusion, drowsiness, visual disturbance
Papilloedema on fundoscopy
Seizures in severe cases (PRES — posterior reversible encephalopathy syndrome)

Management

IV Labetalol: 20 mg IV bolus, then 20–80 mg q10 min (max 300 mg) OR infusion 0.5–2 mg/min
IV Nicardipine: 5 mg/h infusion, titrate up by 2.5 mg/h every 5 min (max 15 mg/h)
Target: reduce MAP by 25% in first hour
Then to 160/100 over next 2–6 hours
Do NOT target normal BP acutely — risk of cerebral ischaemia

DangerRapid normalisation of BP in chronic hypertension causes cerebral ischaemia — autoregulation is reset to higher pressures.

Aortic Dissection

Haemodynamic Targets

SBP target: 100–120 mmHg
Heart rate target: <60 bpm
Achieve within 20 minutes if possible
Reduce wall stress = reduce HR AND BP simultaneously

Drug Protocol

Step 1: IV Esmolol — short-acting beta-blocker, loading 0.5 mg/kg then infusion 50–200 mcg/kg/min
Step 2: IV Sodium Nitroprusside — add if SBP still >120 (NEVER use nitroprusside without beta-blocker first — reflex tachycardia worsens dissection)
IV Labetalol alternative if esmolol unavailable

Key: Give beta-blocker BEFORE vasodilatorVasodilators alone cause reflex tachycardia — increases aortic wall stress and propagates dissection.

Stroke and Hypertension

Ischaemic Stroke (Acute)

Permissive hypertension policy: allow BP up to 220/120 unless thrombolysis planned
Penumbral tissue depends on high perfusion pressure
If tPA (alteplase) candidate: must achieve BP <185/110 before thrombolysis, then maintain <180/105 for 24h post-lysis
Agents: IV labetalol 10–20 mg, nicardipine infusion
Avoid sublingual nifedipine — precipitous drop

Haemorrhagic Stroke (ICH)

SBP ≥150 → treat to 140 mmHg (INTERACT2 trial)
Aggressive lowering may be safe but uncertain benefit
IV labetalol or nicardipine preferred

Eclampsia & HELLP Syndrome

Diagnostic Criteria (Preeclampsia)

BP ≥140/90 after 20 weeks gestation + proteinuria OR other features
Severe: BP ≥160/110, thrombocytopenia, renal failure, headache, visual symptoms
HELLP: Haemolysis, Elevated Liver enzymes, Low Platelets
Eclampsia = seizures in preeclamptic woman

Emergency Management

MgSO4: seizure prophylaxis AND treatment — loading 4 g IV over 20 min, maintenance 1–2 g/h; monitor Mg toxicity (loss of reflexes, respiratory depression — antidote: IV calcium gluconate)
IV Hydralazine: 5–10 mg IV q20 min
IV Labetalol: 20 mg IV, repeat q10 min
Oral Nifedipine: 10–20 mg oral (NOT sublingual)
Target: SBP 140–155, DBP 90–105 (avoid excessive lowering — foetal perfusion)
Definitive treatment: delivery

Antihypertensive Medications

ABCD Framework — First-Line Drug Classes

Class	Examples	Key Indications	Cautions / Avoid
A — ACEi / ARB	Enalapril, Ramipril / Losartan, Valsartan	DM, CKD (proteinuria), HF with reduced EF, post-MI, LV hypertrophy	Pregnancy (CONTRAINDICATED), bilateral RAS, hyperkalaemia, angioedema (ACEi — switch to ARB)
B — Beta-blockers	Atenolol, Bisoprolol, Carvedilol, Metoprolol	HFrEF, post-MI, AF rate control, angina, pregnancy	Asthma/COPD (non-selective), peripheral artery disease, metabolic syndrome, 2nd/3rd degree AV block
C — Calcium Channel Blockers	Amlodipine (DHP), Nifedipine / Diltiazem, Verapamil (non-DHP)	Elderly ISH, angina, Afro-Caribbean patients, CCB angina	Non-DHP: avoid in HFrEF. DHP: peripheral oedema (dose-related, reduce with ACEi combination)
D — Diuretics	Indapamide (thiazide-like, preferred), HCTZ / Furosemide, Torasemide	Systolic HF (loop), oedema, ISH, elderly, Afro-Caribbean	Gout (thiazides), hypokalaemia, hyponatraemia; Loop diuretics for CKD eGFR <30

ACE Inhibitors / ARBs — Clinical Pearls

First-line in diabetes with microalbuminuria — renoprotective beyond BP lowering
ACEi dry cough (10–20%, higher in Asian populations) — switch to ARB
Monitor K+ and creatinine 1–2 weeks after initiation or dose increase
eGFR may drop 10–15% on starting — acceptable if <30% rise in creatinine
Never combine ACEi + ARB (ONTARGET trial — no benefit, more AKI/hyperkalaemia)
Angioedema risk: ACEi — can be life-threatening; higher risk in Black patients
RAAS blockers CONTRAINDICATED in pregnancy — foetal renal tubular dysgenesis, oligohydramnios, neonatal anuria

Combination Therapy & Single-Pill Combinations (SPCs)

Why Combination?

Most patients need ≥2 drugs for adequate control
Synergistic mechanisms — RAS + diuretic + CCB
Lower doses of each → fewer side effects
SPCs significantly improve adherence (pill burden reduction)

Preferred Combinations (ESC/ESH)

ACEi/ARB + CCB — first choice (synergistic, reduces oedema)
ACEi/ARB + thiazide
ACEi/ARB + CCB + thiazide — triple pill (e.g., Valsartan/Amlodipine/HCTZ)

GCC Formulary SPC Examples

Valsartan/HCTZ Telmisartan/HCTZ Amlodipine/Valsartan Perindopril/Amlodipine Bisoprolol/Amlodipine

Drug Selector by Comorbidity

Select Patient Comorbidity / Special Situation:

RAAS Blockers in Pregnancy — ABSOLUTE CONTRAINDICATION: ACE inhibitors and ARBs cause foetal renal tubular dysgenesis, anuria, oligohydramnios, and can be fatal to the foetus. Safe alternatives in pregnancy: methyldopa, labetalol, nifedipine (extended release).

BP Measurement Excellence

ANSI/AAMI Standard BP Measurement Technique

Patient Preparation

Rest quietly for 5 minutes before measurement
Empty bladder (full bladder raises BP 10–15 mmHg)
No caffeine for 30 minutes prior
No exercise for 30 minutes prior
No smoking for 30 minutes prior
No talking during measurement
Avoid tight clothing on upper arm
Comfortable, temperate environment

Patient Position

Seated: back supported against chair
Feet flat on the floor (crossing legs raises SBP ~8 mmHg)
Arm supported at heart level (mid-sternal)
Arm relaxed, slightly flexed at elbow
Palm facing upward

Cuff Application

Cuff bladder should encircle 80% of arm circumference
Wrong cuff size = most common error in BP measurement
Too small cuff → falsely HIGH reading
Too large cuff → falsely LOW reading
Lower edge of cuff: 2–3 cm above antecubital fossa
Cuff must be over bare skin or thin cotton — not over thick sleeve
Artery marker over brachial artery

Cuff Sizes Guide

Cuff Size	Arm Circumference
Small adult	22–26 cm
Standard adult	27–34 cm
Large adult	35–44 cm
Thigh cuff	45–52 cm

Auscultatory Method — Korotkoff Sounds

Phase I: First appearance of tapping sounds = systolic BP
Phase II: Murmur / swishing sounds
Phase III: Crisper, louder sounds return
Phase IV: Muffling of sounds
Phase V: Disappearance of sounds = diastolic BP (use Phase IV if sounds persist to zero — e.g., aortic regurgitation, pregnancy)
Auscultatory gap: Temporary disappearance between Phase II and III — can falsely lower SBP estimate

Inflate to ~30 mmHg above palpated radial pulse disappearanceThis prevents missing the auscultatory gap and ensures accurate SBP identification.

Oscillometric vs Auscultatory

Feature	Oscillometric	Auscultatory
Operator dependency	Low	High
Arrhythmias	Unreliable in AF	More reliable
White coat effect	Less attentive	Observer present
Validation	AAMI/ESH validated models	Gold standard
Preferred setting	HBPM, screening	Clinical diagnosis

Bilateral Arm Difference

>10 mmHg difference: suspect subclavian stenosis on lower side
>15 mmHg difference = clinically significant — vascular disease, coarctation, aortic dissection
Always use higher reading arm for ongoing monitoring
First visit: measure both arms

Orthostatic Hypotension Assessment

Protocol

Patient lies supine for 5 minutes → record BP and HR
Patient sits upright → record at 1 minute
Patient stands → record at 1 minute and 3 minutes
Note any symptoms: dizziness, presyncope

Definition of Orthostatic Hypotension

SBP drop ≥20 mmHg OR DBP drop ≥10 mmHg
Within 3 minutes of standing
Classic OH: within 1 min; Delayed OH: 3–10 min

Clinical Relevance

Prevalence increases with age and antihypertensive treatment
Associated with falls, syncope, fractures in elderly
Check in: elderly, diabetics (autonomic neuropathy), Parkinson's, diuretic/alpha-blocker use

Management

Review medications (reduce/change antihypertensives, avoid alpha-blockers at night)
Increase fluid/salt intake (where appropriate)
Compression stockings
Rise slowly — sit at bedside before standing
Fludrocortisone or midodrine if severe

Lifestyle & Self-Management

DASH Diet — Dietary Approaches to Stop Hypertension

Recommended (Increase)

Fruits and vegetables (8–10 servings/day)
Low-fat dairy (2–3 servings/day) — calcium, potassium
Whole grains — fibre and magnesium
Nuts, seeds, legumes (4–5 servings/week)
Lean poultry and fish
Potassium-rich foods: bananas, potatoes, spinach, beans, avocado (target 4700 mg/day)
Magnesium-rich: nuts, seeds, leafy greens

Reduce / Limit

Red meat and processed meat
Saturated and trans fats
Added sugars and sweetened beverages
Sodium: <2 g/day (=<5 g salt/day)
GCC-relevant: preserved fish (hammour), canned foods, fast food, ghee-heavy dishes

BP Reduction from DASH Alone

Intervention	SBP Reduction
DASH diet	2–4 mmHg
Na restriction	2–8 mmHg
Combined	Up to 12 mmHg

Physical Activity

Target: 150 min/week moderate aerobic (or 75 min vigorous)
Types: brisk walking, cycling, swimming, dancing
Add 2 days resistance/strength training
SBP reduction: 4–9 mmHg with regular aerobic exercise
GCC context: extreme heat limits outdoor activity — indoor facilities, malls, gyms
Start low, go slow — especially in uncontrolled HTN (>180/110, avoid vigorous until controlled)
Isometric exercises (handgrip training) also evidence-based

Weight & Waist

~1 mmHg SBP reduction per kg lost
Target BMI: 20–25 kg/m² (Asian: <23)
Waist circumference goals:
Men: <94 cm (European), <90 cm (Asian/South Asian)
Women: <80 cm
Central/abdominal obesity strongly linked to HTN, insulin resistance
Even 5% body weight loss meaningful
Obesity surgery can normalise BP in morbidly obese

Smoking & Alcohol

Smoking

Each cigarette raises BP transiently 5–10 mmHg
Smoking cessation reduces CVD risk substantially — does not lower resting BP significantly but drastically cuts CV risk
Offer NRT, varenicline, counselling
Shisha/hookah equally harmful — common in GCC

Alcohol (GCC Context)

Majority of GCC population are non-drinkers (religious practice)
Where relevant: limit ≤14 units/week (men), ≤8 (women)
Alcohol raises BP and blunts drug response

Sleep Apnoea & Stress

Obstructive Sleep Apnoea (OSA)

OSA causes non-dipping nocturnal hypertension and resistant HTN
Screen with Epworth, STOP-Bang, or sleep study
CPAP treatment: reduces nocturnal BP by 2–4 mmHg
High prevalence in obese GCC populations
Suspect in: snoring, witnessed apnoeas, uncontrolled HTN despite multiple drugs

Stress Management

Chronic psychosocial stress activates sympathetic nervous system
Mindfulness, breathing exercises, yoga — modest BP reduction (2–5 mmHg)
Cognitive behavioural therapy for work-related stress
Adequate sleep (7–8 hours) independently cardioprotective

Patient Self-Monitoring Education

Teach correct HBPM technique (see Tab 4)
Provide BP diary / smartphone app
Define action thresholds: when to seek care (>180/110 or symptoms)
Educate on medication adherence — most important modifiable factor
Dispel myths: "I feel fine so BP must be OK" — HTN is asymptomatic
Explain the meaning of target BP — motivate by linking to stroke/heart attack prevention
Cultural communication: involve family in GCC context, provide Arabic materials
Medication timing: once-daily drugs — preferably at consistent time (many prefer evening dosing for nocturnal dipping)
Side effect counselling to prevent premature discontinuation

GCC Hypertension Context

Epidemiology in the GCC

Prevalence: 25–40% of adults in GCC countries
Adults over 50 years: prevalence rises to 50%
Awareness rate: moderate — many untreated despite knowing diagnosis
Control rate: poor — only 30–40% of treated patients at target
Rising HTN in young adults — driven by obesity epidemic
GCC countries among highest in world for BMI and type 2 diabetes
High rates of secondary HTN (aldosteronism frequently under-diagnosed)
Co-morbidity burden: DM + HTN extremely common combination

GCC-Specific Risk Factors

Diet

High sodium diet: preserved fish (hammour, harees), salty cheese, canned goods
Ghee-heavy traditional cooking — saturated fat burden
High sugar intake — beverages, dates in excess
Low fruit/vegetable consumption in some population segments
Food portion sizes increasing with urbanisation

Physical Inactivity

Extreme summer heat (up to 50°C) forces indoor/sedentary lifestyle 5–6 months/year
Car-centric urban design with minimal walking infrastructure
High domestic worker utilisation reduces physical exertion
Screen time and desk jobs increasing

Ramadan and Antihypertensive Management

Challenges During Ramadan

Disrupted meal and sleep timing
Daytime fasting (water restriction) — risk of dehydration and BP changes
Large evening meal (Iftar) may cause post-prandial BP changes
Night-time eating and sleep deprivation affect circadian BP rhythm
Patients often self-adjust or stop medications — risk of rebound hypertension

Medication Adjustments

Once-daily medications preferred — take at Iftar (sunset meal)
Evening dosing also beneficial for nocturnal dipping
Avoid diuretics during fasting hours — dehydration risk, difficulty passing urine at work
Diuretics: switch to Iftar dosing or reduce dose under supervision
ABPM during Ramadan useful to reassess control and adjust regimen
Counsel patients NOT to self-stop medications — explain fasting exemption for medical need

Ramadan-Compatible Drug Choices

Class	Ramadan Suitability
Once-daily ARB/ACEi	Excellent — take at Iftar
Long-acting CCB (amlodipine)	Excellent
Once-daily beta-blocker	Good
Thiazide/thiazide-like	Caution — adjust timing
Loop diuretics	Avoid daytime — Iftar only if needed
Twice-daily formulations	Switch to OD if possible

Leading GCC Cardiology & HTN Centres

UAE

Sheikh Khalifa Medical City (SKMC) — Abu Dhabi, JCI-accredited, advanced HTN/cardiology
Cleveland Clinic Abu Dhabi — comprehensive cardiovascular programme
NMC Healthcare — large network, hypertension clinics across UAE
Mediclinic — multi-site, specialist cardiology, ABPM services
Dubai Health Authority (DHA) NCD programmes

Other GCC

King Faisal Specialist Hospital (Riyadh, KSA)
Hamad Medical Corporation (Qatar)
King Hamad University Hospital (Bahrain)
National BP awareness campaigns: UAE Heart Month, Saudi Healthy Heart

Risk Stratifier Calculator

Systolic BP (mmHg): Diastolic BP (mmHg): Number of CV Risk Factors (smoking, DM, dyslipidaemia, obesity, family history, age M>55/F>65): Target Organ Damage / Clinical CVD:

Practice MCQs — Hypertension Nursing

GCC Nurse Hypertension Guide — Based on ESC/ESH 2023 and ACC/AHA 2017 Guidelines. For educational use only. Clinical decisions must involve qualified clinicians.